{
    "2018-08-30": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer’s Quarterly Revenues and Estimates for 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "quarterly revenues",
                        "estimates",
                        "2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-15",
                "original_text": "Pfizer’s Developments in August",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "developments",
                        "August"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-31",
                "original_text": "Pfizer’s Stock Performance in August",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "stock performance",
                        "August"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-29",
                "original_text": "Why K2M Group Holdings, Inc. Acquired a Higher Price Today",
                "features": {
                    "keywords": [
                        "K2M Group Holdings",
                        "higher price",
                        "acquisition"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-28",
                "original_text": "AstraZeneca (AZN) Gets EU Nod for New Formulation of Bydureon",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "EU nod",
                        "Bydureon",
                        "new formulation"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-27",
                "original_text": "Better Buy: Johnson & Johnson vs. Merck",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Merck",
                        "better buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "Morning News Call - India, August 30",
                "features": {
                    "keywords": [
                        "morning news call",
                        "India",
                        "August 30"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}